Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05250037 · ClinicalTrials.gov registry record

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

A clinical trial of Hematopoietic and Lymphoid Cell Neoplasm and Bronchiolitis Obliterans Syndrome, sponsored by Fred Hutchinson Cancer Center.

Recruiting
Registry status
250
Enrollment target
4
Study locations

NCT05250037: Recruiting study of Hematopoietic and Lymphoid Cell Neoplasm and Bronchiolitis Obliterans Syndrome, sponsored by Fred Hutchinson Cancer Center.

NCT05250037 is a study of Hematopoietic and Lymphoid Cell Neoplasm and Bronchiolitis Obliterans Syndrome that is actively recruiting participants, run by Fred Hutchinson Cancer Center. The registered enrollment target is 250 participants, below the 951-participant average among 104 other Hematopoietic and Lymphoid Cell Neoplasm trials with a reported enrollment target (74% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05250037, a study of Hematopoietic and Lymphoid Cell Neoplasm and Bronchiolitis Obliterans Syndrome, is actively recruiting participants, sponsored by Fred Hutchinson Cancer Center.

RECRUITING
Registry status
250 participants
Enrollment target
4
Study locations

Study Summary

This observational trial studies whether respiratory viruses are the cause of lung disease (bronchiolitis obliterans syndrome \[BOS\] or graft-versus-host disease of the lung) and changes in lung function in patients who have received a donor stem cell transplant. Patients with chronic graft-versus-host disease (cGVHD) are at higher risk of developing BOS. Studies have also shown that patients who had a respiratory viral illness early after their transplant are at higher risk of developing lung problems later on. Patients who are at risk and who already have BOS might benefit from being monitored more closely. Spirometry is a way of assessing a patient's lung function and is often used to diagnose lung disease. Spirometry measured at home with a simple handheld device may reduce the burden of performing pulmonary function testing at a facility and potentially help patients get their lung disease diagnosed and treated sooner.

Primary Outcome

Diagnosed by National Institute of Health criteria or clinical diagnosis in the absence of alternative diagnosis.

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Questionnaire Administration
  • PROCEDURE Home spirometry

Study Locations (4)

California

  • Stanford Cancer Institute - Palo Alto

Michigan

  • University of Michigan Cancer Center - Ann Arbor

Texas

  • MD Anderson Cancer Center - Houston

Washington

  • Fred Hutch/University of Washington Cancer Consortium - Seattle

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2022-03-30
Est. Completion 2028-06-30
Fred Hutchinson Cancer Center

483 total trials

What NCT05250037 shows while recruiting

NCT05250037 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 951-participant average among 104 other Hematopoietic and Lymphoid Cell Neoplasm trials with a reported enrollment target (74% lower).

The record links to 2 conditions, with Hematopoietic and Lymphoid Cell Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.

NCT05250037 reports a single indexed study location in California, Michigan, Texas.

Frequently Asked Questions

What is clinical trial NCT05250037 about?

NCT05250037 is a clinical study titled "The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)". This observational trial studies whether respiratory viruses are the cause of lung disease (bronchiolitis obliterans syndrome \[BOS\] or graft-versus-host disease of the lung) and changes in lung function in patients who have received a donor stem cell transplant. Patients with chronic graft-versus-...

What is the current status of trial NCT05250037?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2022-03-30. Estimated completion is 2028-06-30.

What conditions does trial NCT05250037 study?

This clinical trial studies the following conditions: Hematopoietic and Lymphoid Cell Neoplasm, Bronchiolitis Obliterans Syndrome.

What interventions are being tested in trial NCT05250037?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER), Home spirometry (PROCEDURE).

Who is sponsoring clinical trial NCT05250037?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05250037 being conducted?

This trial has 4 study locations across California, Michigan, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hematopoietic and Lymphoid Cell Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05250037's enrollment target sits among peer trials

250 25th of 104 higher than 79 of 104 other Hematopoietic and Lymphoid Cell Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hematopoietic and Lymphoid Cell Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05250037, the US trial registry maintained by the National Library of Medicine. NCT05250037 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.